Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ergotamine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine + ergotamine tartrate 100mg/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine + ergotamine tartrate 100mg/2mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine + ergotamine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ergotamine tartrate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergotamine + caffeine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has precise active ingredient |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has basis of strength substance (attribute) |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has precise active ingredient |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ergotamine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |